Stockscreener 앱 받기
2.72
3.20%
-0.09
시간 외 거래:
2.73
0.010
+0.37%
전일 마감가:
$2.81
열려 있는:
$2.74
하루 거래량:
25,610
Relative Volume:
0.05
시가총액:
$4.81M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-10.82%
1개월 성능:
-8.88%
6개월 성능:
-80.93%
1년 성능:
-97.53%
1일 변동 폭
$2.70
$2.80
1주일 범위
$2.63
$3.10
52주 변동 폭
$2.55
$112.80
Autonomix Medical Inc Stock (AMIX) Company Profile
명칭
Autonomix Medical Inc
전화
832-277-7816
주소
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
AMIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
2.72 | 4.81M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Autonomix Medical Inc 주식(AMIX)의 최신 뉴스
Autonomix Medical Hires Regulatory Affairs and Quality VP - MPO-mag
Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Grows By 159.2% - Defense World
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment -January 27, 2025 at 11:05 am EST - Marketscreener.com
Financial Survey: Autonomix Medical (NASDAQ:AMIX) & Becton, Dickinson and Company (NYSE:BDX) - Defense World
Autonomix Medical, Inc. Chief Executive Officer Participated in Virtual Investor EventAutonomix Medical, Inc. (NASDAQ: AMIX) recently disclosed in an 8-K filing that its Chief Executive Officer, Brad Hauser, took part in the “Virtual Investor Closing - Defense World
Final Design Set for Autonomix Medical’s RF Ablation Catheter - MPO-mag
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment - The Manila Times
Autonomix Medical CEO Shares Key Insights from JPM Healthcare Conference - StockTitan
Autonomix Medical finalizes ASIC microchip design - MSN
Autonomix Medical finalizes ASIC microchip design By Investing.com - Investing.com Canada
Autonomix Medical, Inc. Finalizes Design of ASIC Microchip - GlobeNewswire
Autonomix Medical Locks ASIC Microchip Design, Advances Toward Pancreatic Cancer Pain Treatment - StockTitan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series - The Manila Times
Autonomix Medical CEO to Present Company Vision at Virtual Investor Closing Bell Series - StockTitan
Autonomix Medical, Inc. Announces Abstract Highlighting - GlobeNewswire
Autonomix Medical to Present First Clinical Data on Novel Pancreatic Cancer Pain Treatment at SIO 2025 - StockTitan
Autonomix Medical Shares Rise on New Patent for Cancer Treatment - MarketWatch
What's Going On With Autonomix Medical Stock Monday? - Benzinga
Autonomix granted U.S. patent for catheter-based technology - TipRanks
Autonomix Medical, Inc. Announces U.S. Patent Granted - GlobeNewswire
Autonomix Medical Patents Breakthrough Cancer Pain Treatment with 3000x Greater Sensitivity - StockTitan
Autonomix Medical CEO Unveils Strategic Vision in Latest Corporate Update - StockTitan
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality - The Manila Times
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial - GlobeNewswire
Autonomix Medical Strengthens FDA Strategy with Key Regulatory Hire Ahead of Clinical Trials - StockTitan
Autonomix Medical (AMIX) & The Competition Critical Survey - Defense World
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward A U.S. Pivotal Trial in 2025 - Marketscreener.com
Contrasting Autonomix Medical (AMIX) & Its Competitors - Defense World
Autonomix achieves design lock for RF Ablation Catheter - TipRanks
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025 - GlobeNewswire
Autonomix Medical's Revolutionary Pain Treatment Shows 3,000x Sensitivity in Breakthrough Testing - StockTitan
AMIXAutonomix Medical, Inc. Latest Stock News & Market Updates - StockTitan
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option - The Manila Times
Autonomix Medical, Inc. Announces Closing of $10.0 Million - GlobeNewswire
Autonomix Medical Closes $10M Public Offering with Warrants to Fund Clinical Trials | AMIX Stock News - StockTitan
Autonomix Medical stock dips after pricing $9M securities offering - MSN
Autonomix Medical (NASDAQ:AMIX) vs. Perspective Therapeutics (NYSE:CATX) Critical Review - Defense World
Autonomix Medical (AMIX) & Its Rivals Head to Head Contrast - Defense World
Autonomix Medical Prices of $9.0 Million Underwritten Public Offering - citybiz
Autonomix Medical Down 53% After Pricing of $9M Offering - MarketWatch
Crude Oil Gains Over 1%; Ross Stores Earnings Top Views - Benzinga
Stock market news: Dragonfly Energy Holdings -88.31%, Autonomix Medical -53.33% among top stock losers during mid day trading - Business Upturn
Autonomix Medical slumps after $9 mln stock offering - XM
Stock market today: Dragonfly Energy Holdings -88.07%, Autonomix Medical -52.37% among top losers in early trading - Business Upturn
Dow Jumps 300 Points; Gap Posts Upbeat Earnings - Benzinga
Autonomix to sell 1.38M units at $6.54 in underwritten public offering - TipRanks
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering - GlobeNewswire
Autonomix Medical Prices $9M Public Offering with Warrants to Fund Clinical Trials | AMIX Stock News - StockTitan
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket - Benzinga
A.M.AUTONOMY Showcases MAP-TORCH for 3D Construction Digitalization at KINTEX - GlobeNewswire Inc.
Autonomix Medical Inc (AMIX) 재무 분석
Autonomix Medical Inc (AMIX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
5.14%
2.09%
자본화:
|
볼륨(24시간):